Fig. 8From: Current understanding of the molecular mechanisms in Parkinson's disease: Targets for potential treatmentsBrain areas affected by PD. Substantia nigra in mouse brain (a and b); TH+ DA-neurons in SN (c; 40 x); in control (d) and MPTP-treated mouse brain (e). TH+ fibers in control (f, h) and MPTP-treated (g, i) mouse striatum. Note: The loss of DA-neurons in SN (e), along with loss of TH+ fibers in striatum, have been observed after MPTP treatment (g & i)Back to article page